Related Experiment Video
Updated: May 7, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.2K
Live-attenuated bacteria as a cancer vaccine vector
Bertrand Toussaint1, Xavier Chauchet, Yan Wang
1Laboratoire TIMC-IMAG/TheREx (UMR 5525 CNRS-UJF), UFR de médecine, Université Joseph Fourier Grenoble I, 38700 La Tronche Cedex, France.
Expert Review of Vaccines
|October 16, 2013
Summary
Live-attenuated bacteria are emerging as promising vectors for cancer immunotherapy. Genetically engineered bacteria deliver antigens to antigen-presenting cells (APCs), enhancing immune responses and leading to clinical trials.
Area of Science:
- Oncology
- Immunology
- Microbiology
Background:
- Active and specific cancer immunotherapy is a rapidly developing field.
- Live-attenuated bacterial vectors are gaining traction due to their adjuvant properties and antigen-delivery capabilities.
- Genetic engineering allows customization of bacterial vectors for specific cancer immunotherapy applications.
Purpose of the Study:
- To review the technological advancements in using live-attenuated bacteria as vectors for cancer immunotherapy.
- To highlight the potential of bacterial vectors in enhancing anti-cancer immune responses.
- To discuss the progression from academic research to clinical trials for bacterial cancer therapies.
Main Methods:
- Genetically engineering bacterial species (e.g., Listeria, Salmonella) to express tumor antigens.
- Leveraging the natural adjuvant effects and tropisms of bacteria for targeted delivery.
- Overcoming safety and efficacy challenges through technological innovation.
Main Results:
- Bacterial vectors can be engineered to deliver antigens to antigen-presenting cells (APCs).
- The microbial origin of bacteria provides inherent adjuvant effects, boosting immune responses.
- Different bacterial species offer distinct delivery routes and tropisms for tailored applications.
- Recent advancements have enabled progression to clinical trials for live bacterial cancer immunotherapies.
Conclusions:
- Live-attenuated bacterial vectors represent a significant advancement in cancer immunotherapy.
- Technological progress has established bacteria as a promising platform for developing novel cancer treatments.
- The transition to clinical trials signifies the maturation and therapeutic potential of this approach.
Related Concept Videos
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
01:21Vaccines
105
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
105
02:18Cancer
51.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K